retifanlimab,pembrolizumab,Bria-IMT
Incyte,Merck,BriaCell Therapeutics
['breast']
$bctx 8-k briacell therapeutics (17 apr, 4:50pm) briacell presents positive data demonstrating survival and clinical benefits in advanced metastatic breast cancer at the 2023 aacr #bctx #8k #briacelltherapeutics #news
Feed of new SEC filings and other useful information for stock market investors.